Despite advances in surgery and therapy, Glioblastoma (GBM) remains the most common and deadliest brain cancer in adults. Research shows that Glioblastoma tumor recurrence and therapeutic resistance has been attributed to Glioma-Initiating Cells (GICs) within the tumor that display several characteristics of neural stem cells. “With a median patient survival rate between 10-15 months, identifying… Read More
The University of Tennessee Health Science Center researcher Kafait U. Malik, DSc, PhD, professor in the Department of Pharmacology, has been working in the area of cardiovascular science, with a focus on the mechanism underlying the development of high blood pressure, or hypertension, and its pathogenesis for more than four decades. “I have a zest… Read More
Nearly 200 researchers from the University of Tennessee Health Science Center, Tulane University, and the University of Mississippi Medical Center (UMMC) gathered on Thursday, July 19 for the Delta Clinical and Translational Health Disparities Conference. Envisioned by Steven R. Goodman, PhD, vice chancellor for Research at UTHSC, Richard L. Summers, MD, vice chancellor for Research… Read More
Researchers at the University of Tennessee Health Science Center have formed the Tennessee Clinical and Translational Science Institute (TN-CTSI) to address health inequities in the Southern United States. According to the U.S. Census Bureau, the American South represented the largest population growth by region in 2017. Comprised of 17 states stretching from Texas, Oklahoma, and… Read More